Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Colorectal Disease|April 5, 2016
Laparoscopic ventral mesh rectopexy in complex pelvic floor disorderK Horisberger, A Rickert, S Templin, et al.
The Journal of Infection|October 26, 2001
Spontaneous bacterial peritonitis and bacteremia due to Leuconostoc species in a patient with end-stage liver disease: a case reportK S Templin, T Crook, T Riley, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Maturation of dendritic cells from ovarian cancer patientsE Zavadova, C A Savary, S Templin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinomaB Melichar, C A Savary, R Patenia, et al.
Journal of Immunological Methods|January 3, 1994
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapyR S Freedman, B Tomasovic, S Templin, et al.
Anesthesiology|August 18, 2015
Neosaxitoxin in Rat Sciatic Block: Improved Therapeutic Index Using Combinations with Bupivacaine, with and without EpinephrineJay S Templin, Matthew C Wylie, Joseph D Kim, et al.
Neuroscience|December 7, 2010
A greater role for the norepinephrine transporter than the serotonin transporter in murine nociceptionF S Hall, J M Schwarzbaum, M T G Perona, et al.
International Journal of Obesity (2005)|August 11, 2011
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat contentA Peter, K Kantartzis, F Machicao, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trialR S Freedman, C L Edwards, J J Kavanagh, et al.
The Journal of Clinical Endocrinology and Metabolism|February 29, 2024
An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid CancersRhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor, et al.
Pageof 2